NovelDx in the News

CARB-X Funding Announcement

CARB-X Funding Announcement

 April 6th, 2021, 7:00 AM ET  Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections      (Baltimore, Maryland) - Novel Microdevices, Inc.,(Novel) a developer of an innovative molecular diagnostics platform, announced today that CARB-X has awarded it up to $13.8 million in non-dilutive funding to develop its next-generation rapid molecular test for the diagnosis of sexually transmitted bacterial infections,...

Sign Up for Updates